280 related articles for article (PubMed ID: 27212706)
1. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
[TBL] [Abstract][Full Text] [Related]
2. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
4. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.
Fèvre EM; Odiit M; Coleman PG; Woolhouse ME; Welburn SC
BMC Public Health; 2008 Mar; 8():96. PubMed ID: 18366755
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
[TBL] [Abstract][Full Text] [Related]
6. A mathematical model for evaluating the role of trypanocide treatment of cattle in the epidemiology and control of
Meisner J; Barnabas RV; Rabinowitz PM
Parasite Epidemiol Control; 2019 May; 5():e00106. PubMed ID: 31061906
[TBL] [Abstract][Full Text] [Related]
7. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
[TBL] [Abstract][Full Text] [Related]
8. Update on human African trypanosomiasis (sleeping sickness).
Kennedy PGE
J Neurol; 2019 Sep; 266(9):2334-2337. PubMed ID: 31209574
[TBL] [Abstract][Full Text] [Related]
9. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the elimination of human African trypanosomiasis: Update to 2016.
Franco JR; Cecchi G; Priotto G; Paone M; Diarra A; Grout L; Simarro PP; Zhao W; Argaw D
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006890. PubMed ID: 30521525
[TBL] [Abstract][Full Text] [Related]
11. The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets.
Franco JR; Priotto G; Paone M; Cecchi G; Ebeja AK; Simarro PP; Sankara D; Metwally SBA; Argaw DD
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012111. PubMed ID: 38626188
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
13. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
[TBL] [Abstract][Full Text] [Related]
14. Healthcare Management of Human African Trypanosomiasis Cases in the Eastern, Muchinga and Lusaka Provinces of Zambia.
Mwiinde AM; Simuunza M; Namangala B; Chama-Chiliba CM; Machila N; Anderson NE; Atkinson PM; Welburn SC
Trop Med Infect Dis; 2022 Sep; 7(10):. PubMed ID: 36288011
[TBL] [Abstract][Full Text] [Related]
15. Sleeping sickness in Uganda: a thin line between two fatal diseases.
Picozzi K; Fèvre EM; Odiit M; Carrington M; Eisler MC; Maudlin I; Welburn SC
BMJ; 2005 Nov; 331(7527):1238-41. PubMed ID: 16308383
[TBL] [Abstract][Full Text] [Related]
16. Does a One Health approach to human African trypanosomiasis control hasten elimination? A stochastic compartmental modeling approach.
Meisner J; Kato A; Lemerani MM; Miaka EM; Ismail AT; Wakefield J; Rowhani-Rahbar A; Pigott D; Mayer JD; Lorton C; Rabinowitz PM
Acta Trop; 2023 Apr; 240():106804. PubMed ID: 36682395
[TBL] [Abstract][Full Text] [Related]
17. Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004-2014).
Mwiinde AM; Simuunza M; Namangala B; Chama-Chiliba CM; Machila N; Anderson N; Shaw A; Welburn SC
Infect Dis Poverty; 2017 Oct; 6(1):150. PubMed ID: 29017597
[TBL] [Abstract][Full Text] [Related]
18. Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme.
Lee SJ; Palmer JJ
Infect Dis Poverty; 2018 Aug; 7(1):84. PubMed ID: 30119700
[TBL] [Abstract][Full Text] [Related]
19. The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach.
Meisner J; Kato A; Lemerani MM; Mwamba Miaka E; Ismail Taban A; Wakefield J; Rowhani-Rahbar A; Pigott DM; Mayer JD; Rabinowitz PM
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010155. PubMed ID: 36037205
[TBL] [Abstract][Full Text] [Related]
20. Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.
Simarro PP; Cecchi G; Franco JR; Paone M; Diarra A; Ruiz-Postigo JA; Mattioli RC; Jannin JG
Int J Health Geogr; 2014 Feb; 13():4. PubMed ID: 24517513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
